Here are five details:
1. The company’s second quarter revenue topped $36.4 million, a 6.5 percent increase year-over-year.
2. In the U.S., SeaSpine recorded $32.6 million in revenue, a 7.5 percent increase year-over-year.
3. SeaSpine’s spine implants segment generated $17.8 million in revenue, a 7.2 percent increase year -over-year. The company attributed the growth to the launch of its Shoreline and Mariner systems.
4. The company’s orthobiologics segment increased 5.8 percent year-over-year, recording $18.6 million in revenue.
5. SeaSpine expects full-year revenue to be between $136 million and $139 million, a 3.2 percent to 5.5 percent increase year-over-year.
To view the full financial report, click here.
More articles on devices and implants:
3 things to know about Shukla Medical
Medtronic among leaders in sustainability: 3 notes
Globus Medical expands further into computer assistance, robotics with Surgimap acquisition: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
